Articles by Rich Whitworth - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Rich Whitworth

EMA Welcomes New Directive on Falsified Medicines

Jul 7, 2011

The European Medicines Agency has responded positively to a new directive published in the Official Journal of the European Union addressing concerns over increases in falsified medicines in the supply chain.

Calling the Shots: Innovation in Controlled-Release Injectables

High demand could lead to innovation in controlled-release injectables.
Jul 2, 2011

High demand could lead to innovation in controlled-release injectables.

Swiss, Please!

Jul 1, 2011

One of the perks of my job is that I can travel to previously unvisited cities. This month, I was lucky enough to be in Switzerland.

EMA Stakeholder Forum on Pharmacovigilance

Jun 30, 2011

The European Medicines Agency (EMA) has held a second forum regarding the implementation of new pharmacovigilance legislation, which gave stakeholders the opportunity to discuss their expectations on various aspects of the new legislation's execution.

Independent Expert Advises EMA on Benefit/Risk Communication

Jun 2, 2011

An independent report released by the European Medicines Agency highlighted a number of recommendations to aid the agency in its communication of the benefits and risks of medicines.

Celebration And Cinema

Jun 1, 2011

It was a mixed crowd hosted by Dusseldorf in the middle of May.

Teva Snatches Cephalon from Valeant

May 5, 2011

Israel-based Teva Industries seals deal to acquire Cephalon for $6.8 billion.

Inter city tales

May 3, 2011

As I strolled through Times Square, famous brand coffee cup in hand, towards the Jacob K. Javits Convention Center in New York, my thoughts were entirely focused on Interphex.

Warner Chilcott to Axe 500 European Jobs

Apr 28, 2011

Warner Chilcott announced in a press release on Apr. 18, 2011, its intentions restructure, placing 500 Western European jobs on the line.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here